Detailed Notes on WB403
data demonstrating TGR5 modulation and GLP-one activation potential, glucose tolerance advancement, preservation for mass and performance of pancreatic β-cells, as well as absence of gallbladder filling facet effect, represented a promising novel prospect for anti-diabetic drug improvement. The identification and characterization of WB403 not just